Creative Planning Acquires Shares of 2,975 U.S. Physical Therapy, Inc. (NYSE:USPH)

Creative Planning bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,975 shares of the company’s stock, valued at approximately $252,000.

A number of other institutional investors also recently modified their holdings of the stock. Silvercrest Asset Management Group LLC purchased a new stake in shares of U.S. Physical Therapy during the first quarter worth $8,158,000. Renaissance Technologies LLC raised its stake in shares of U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after purchasing an additional 61,474 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after buying an additional 10,175 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its holdings in U.S. Physical Therapy by 4.1% in the second quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after buying an additional 9,434 shares during the last quarter.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of analyst reports. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $95.08 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27. The firm has a fifty day simple moving average of $83.62 and a 200-day simple moving average of $91.44. The stock has a market capitalization of $1.43 billion, a price-to-earnings ratio of 101.15, a PEG ratio of 4.67 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 1-year low of $76.18 and a 1-year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.76 EPS. On average, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.54 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 annualized dividend and a yield of 1.85%. U.S. Physical Therapy’s payout ratio is 187.23%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.